Obat provides invoicing and payment software tailored for contractors and independent contractors in the construction industry. The platform is designed to meet the needs of small and medium enterprises by offering features such as project management, site monitoring, and building craftsmen invoices. Obat continuously updates its software based on feedback from customers and partners, ensuring that it remains relevant and effective in helping clients streamline their operations and enhance their value proposition.
Cachet is a "trustee" data layer between the sharing economy platforms and insurance providers. We aggregate and enrich cross-market data about how much service providers are providing service on various competing platforms and via that enable insurance companies to sell more personalised coverage. We have started with the ride-hailing/mobility sector since it has the highest number of participants.
RollingFunds is a French fintech company founded in 2018 and headquartered in Paris. It specializes in providing short-term financing to small and medium enterprises (SMEs) through a credit management platform. The company leverages data and technology, employing instant scoring algorithms based on machine learning to streamline the loan application and approval process. This approach allows RollingFunds to offer real-time loans tailored to the specific needs of SMEs, simplifying their access to cash financing and enabling them to better serve their partners.
Cake App mission is to become the leading software technology provider that analyzes financial data to help people better understand, control and improve their finances, supported by a business model that shares our revenue with users.
IPaidThat automatically imports the invoices you receive, and compares them with your bank transactions, to make sure you do not forget anything.
Monisnap SAS operates a digital instant money transfer platform and mobile application, enabling users to send money abroad quickly and efficiently. Founded in 2017 and based in Paris, France, the company targets the remittance market, addressing issues such as high fees and low customer satisfaction commonly associated with traditional services. Monisnap allows users to transfer money from Europe to various locations worldwide, facilitating transactions for individuals and businesses alike. The company is authorized to function as a banking intermediary by the French Financial Authority, highlighting its commitment to regulatory compliance and customer trust. Monisnap aims to provide a competitive alternative in the money transfer sector through its user-friendly platform and transparent fee structure.
Zaion SAS, founded in 2017 and based in Paris, France, specializes in developing integrated oral and written conversation solutions, including callbot and voicebot technologies. The company offers AI-powered platforms that automate customer interactions through natural language processing, allowing businesses to manage both voice and text-based communications effectively. Zaion's solutions enable the supervision of customer interactions, provide insightful reporting, and facilitate integration with information systems and customer relationship management (CRM) systems. By leveraging artificial intelligence, Zaion enhances customer relationship management, helping companies build personalized connections and achieve immediate responses, thereby improving customer satisfaction and reducing operational costs.
Acasi SAS develops accounting management software for freelancers. It offers online quotation and invoicing, managing VAT, automatic transmission of your expenses, cash in real time, and automatic accounting management. The company was incorporated in 2017 and is based in Paris, France.
MONEYTRACK SAS provides a blockchain-based directed payment platform for insurance reimbursement services. Its platform validates payment contracts between financiers, issuers, beneficiaries, merchants, and payment institutions in the directed payment chain. The company was founded in 2018 and is based in Paris, France.
Smile&Pay SAS, founded in 2007 and based in Paris, France, specializes in card payment solutions tailored for smartphones and tablets. The company provides electronic payment terminals designed for small and medium-sized merchants, enabling them to accept payments from a broad customer base without any fixed fees. Its product lineup includes PocketSmile, a compact mobile terminal that accepts all credit cards, and MaxiSmile, which features a printer and mobile GPRS capabilities. Additionally, Smile&Pay offers a service that allows users to track their receipts in real time through their computers or smartphones, catering to contractors, retailers, and the self-employed.
Particeep is a fintech that provides banks, asset management firms, insurances and their distributors an API technology, enabling them to distribute their financial products and services online. The company offers, in addition to its API integrating ready-to-use banking and insurance micro-services, white-label platforms to industrialise the online distribution of banking, insurance and investment products.
Particeep is a young innovative firm, winner of the 2017 and 2018 Banque et Innovation Fintech and Open Banking awards, elected Future Fintech European Star 2016 (ICT Awards 2016) and selected by Challenges in the 2016 ranking of 100 startups to invest in
WeGroup NV is an insurance technology company based in Gent, Belgium, with additional offices in the United Kingdom and Poland. Founded in 2017, the company operates a platform designed to enhance the connection between insurance providers and their digital customers. By utilizing data analytics and machine learning algorithms, WeGroup offers a digital assistant named 'Louise,' which aids insurance intermediaries, service providers, and carriers in understanding client needs and risk profiles. This technology facilitates the automation of various processes, including claims handling and compliance, allowing insurance companies to streamline operations, improve sales, and enhance portfolio quality while reducing overhead costs.
Monisnap SAS operates a digital instant money transfer platform and mobile application, enabling users to send money abroad quickly and efficiently. Founded in 2017 and based in Paris, France, the company targets the remittance market, addressing issues such as high fees and low customer satisfaction commonly associated with traditional services. Monisnap allows users to transfer money from Europe to various locations worldwide, facilitating transactions for individuals and businesses alike. The company is authorized to function as a banking intermediary by the French Financial Authority, highlighting its commitment to regulatory compliance and customer trust. Monisnap aims to provide a competitive alternative in the money transfer sector through its user-friendly platform and transparent fee structure.
RollingFunds is a French fintech company founded in 2018 and headquartered in Paris. It specializes in providing short-term financing to small and medium enterprises (SMEs) through a credit management platform. The company leverages data and technology, employing instant scoring algorithms based on machine learning to streamline the loan application and approval process. This approach allows RollingFunds to offer real-time loans tailored to the specific needs of SMEs, simplifying their access to cash financing and enabling them to better serve their partners.
IPaidThat automatically imports the invoices you receive, and compares them with your bank transactions, to make sure you do not forget anything.
Smile&Pay SAS, founded in 2007 and based in Paris, France, specializes in card payment solutions tailored for smartphones and tablets. The company provides electronic payment terminals designed for small and medium-sized merchants, enabling them to accept payments from a broad customer base without any fixed fees. Its product lineup includes PocketSmile, a compact mobile terminal that accepts all credit cards, and MaxiSmile, which features a printer and mobile GPRS capabilities. Additionally, Smile&Pay offers a service that allows users to track their receipts in real time through their computers or smartphones, catering to contractors, retailers, and the self-employed.
MONEYTRACK SAS provides a blockchain-based directed payment platform for insurance reimbursement services. Its platform validates payment contracts between financiers, issuers, beneficiaries, merchants, and payment institutions in the directed payment chain. The company was founded in 2018 and is based in Paris, France.
Géocorail développe et commercialise un produit innovant faisant travailler la mer à la protection du littoral : le Géocorail®. Ce procédé électrochimique breveté innovant consiste à créer une roche artificielle permettant de protéger les ouvrages marins et de lutter contre l’érosion du littoral.
Theraclion is a French company established in 2004, focused on developing, manufacturing, and marketing therapeutic ultrasound equipment. The company specializes in high-intensity focused ultrasound (HIFU) technology and offers innovative echotherapy solutions for non-invasive treatments. Its key products include Echopulse, designed for the ambulatory treatment of breast fibroadenomas and benign thyroid nodules, and SONOVEIN, which targets varicose veins. Theraclion operates in approximately 20 countries, positioning itself as a pioneer in utilizing ultrasound for therapeutic applications.
Myopowers Medical Technologies is a French medical device company that develops innovative technologies to provide muscle assistance to patients with high unmet medical needs. The technology can be applied to a number of indications in the GI, cardiology or urology area. The company focus is the development of ARTUS, a new and unique implantable device for the treatment of stress urinary incontinence. Stress urinary incontinence is a condition that affects millions of people around the world. Unfortunately, currently available products are old with significant limitations such as tissue erosion, infection or mechanical failure leading frequent re-operation. ARTUS is made of smooth and flat silicon cuff placed around the urethra. It is individually actionable and adjustable with a remote control allowing patients easy voiding and the surgeon monitoring and adjusting the cuff. This device is the first artificial urinary system specifically designed to include the treatment of female patients who account for a vast majority of the urinary incontinence market.
Actility is an industry leader in Low Power Wide Area Networks (LPWAN). ThingPark by Actility offers a carrier-grade IoT platform, with a growing ecosystem of partners; low-power, long-range wireless networks for sensors and devices; an operating system and middleware that enables web applications to connect seamlessly with data from different sensors; and a B2B e-commerce market featuring tested and approved IoT device, connectivity, and application partners. Actility is a founding member of the LoRa Alliance™.
Altimmune, Inc. is a clinical-stage biopharmaceutical company based in Gaithersburg, Maryland, focused on developing innovative treatments for liver diseases, obesity, and immune modulation, alongside vaccines for infectious diseases. The company’s pipeline includes HepTcell, an immunotherapeutic candidate aimed at treating chronic hepatitis B, and pemvidutide, a dual GLP-1/glucagon receptor agonist designed for obesity and non-alcoholic steatohepatitis. Altimmune is also advancing several vaccine candidates, including NasoShield, an anthrax vaccine for intranasal administration, NasoVAX, a recombinant intranasal vaccine, and AdCOVID, a single-dose intranasal vaccine against COVID-19. In addition to its human health initiatives, the company is developing veterinary products and has established collaborations for technology development, notably with the University of Alabama at Birmingham for the AdCOVID project. Altimmune aims to address unmet medical and public health needs through its proprietary intranasal delivery technology and ongoing clinical research.
SP3H's values are in tune with the environmental and energetic stakes of the 21st century. For this reason, their company innovates in ground-breaking technology, which aims to reduce carbon dioxide levels and fuel consumption.
CoolGames B.V., founded in 2009 and based in Amsterdam with a satellite office in Tokyo, specializes in the development, distribution, and monetization of casual and social HTML5 games across various platforms, including smartphones, tablets, and desktop PCs. The company has published numerous high-quality games, including well-known titles like Angry Birds, Tetris, Snake, and Battleship, all accessible via cloud technology, which allows for immediate play without any downloads. In addition to its own game portfolio, CoolGames operates a games portal for media brands and game companies, as well as various direct-to-consumer web destinations aimed at casual gamers. The company serves a diverse clientele that includes media companies, websites, telecommunication operators, handset manufacturers, and game developers. CoolGames was previously known as BoosterMedia B.V. until it rebranded in February 2016.
Momac B.V. is a software provider specializing in customer engagement solutions for communication service providers (CSPs). The company develops a multi-screen platform that manages on-device user interfaces for mobile and web applications, facilitating the connection between CSPs and their customers. Momac's cloud-based platform enables the creation and management of personalized interfaces, helping CSPs reduce costs, increase revenue, and quickly launch solutions in the market. The mvolve platform supports mobile internet and application solutions for major operators, including Orange Group, Vodafone, and Telefonica, among others. With a presence in 27 countries and offices in the United States, the United Kingdom, the Netherlands, and France, Momac serves a diverse clientele, bridging the technology gap between internal data systems and customer care across various connected devices. Founded in 1997 and based in Rotterdam, the Netherlands, the company was previously known as YourNews B.V. and became a subsidiary of Sandvine Corporation in 2015.
Carbios SAS is a green chemistry company based in Saint-Beauzire, France, that specializes in developing innovative bioprocesses for the biodegradation and recycling of plastics. Founded in 2011, the company focuses on creating fully biodegradable plastics with a controlled lifespan and has developed methods for recycling plastic waste, particularly PET, into reusable materials. Carbios produces enzymated pellets for biosourced and biodegradable plastics and is also involved in the production of polylactic acid. In collaboration with Novozymes, Carbios aims to enhance enzyme production for the efficient recycling of PET plastics and fibers, contributing to a more sustainable approach to plastic waste management and the development of competitive biosourced polymers.
SP3H's values are in tune with the environmental and energetic stakes of the 21st century. For this reason, their company innovates in ground-breaking technology, which aims to reduce carbon dioxide levels and fuel consumption.
Pharnext SA is a clinical-stage biopharmaceutical company based in Issy-Les-Moulineaux, France, focused on developing therapies for orphan and common neurodegenerative diseases. Founded in 2007 by prominent scientists including Professor Daniel Cohen, Pharnext employs a novel approach called PLEOTHERAPY, which utilizes advanced genomic data and network pharmacology to discover new uses for existing drugs. This process identifies synergistic combinations of approved medications, leading to the development of new therapeutics known as PLEODRUGS. Key products include SYNGILITY, which has completed Phase III trials for Charcot-Marie-Tooth disease type 1A, and PXT864, which has shown promise in Phase II trials for Alzheimer's disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Additionally, Pharnext collaborates with the University Hospital Institute Mediterranee Infection to evaluate repurposed drugs for potential COVID-19 treatment. Through its innovative approach, Pharnext aims to provide effective and safe treatments for diseases with limited therapeutic options.
CoolGames B.V., founded in 2009 and based in Amsterdam with a satellite office in Tokyo, specializes in the development, distribution, and monetization of casual and social HTML5 games across various platforms, including smartphones, tablets, and desktop PCs. The company has published numerous high-quality games, including well-known titles like Angry Birds, Tetris, Snake, and Battleship, all accessible via cloud technology, which allows for immediate play without any downloads. In addition to its own game portfolio, CoolGames operates a games portal for media brands and game companies, as well as various direct-to-consumer web destinations aimed at casual gamers. The company serves a diverse clientele that includes media companies, websites, telecommunication operators, handset manufacturers, and game developers. CoolGames was previously known as BoosterMedia B.V. until it rebranded in February 2016.
Biokinesis
Funding Round in 2011
Biokinesis is a biotechnology company developing new treatments for cancer by targeting a specific kinesin found in several cancers.
Pharnext SA is a clinical-stage biopharmaceutical company based in Issy-Les-Moulineaux, France, focused on developing therapies for orphan and common neurodegenerative diseases. Founded in 2007 by prominent scientists including Professor Daniel Cohen, Pharnext employs a novel approach called PLEOTHERAPY, which utilizes advanced genomic data and network pharmacology to discover new uses for existing drugs. This process identifies synergistic combinations of approved medications, leading to the development of new therapeutics known as PLEODRUGS. Key products include SYNGILITY, which has completed Phase III trials for Charcot-Marie-Tooth disease type 1A, and PXT864, which has shown promise in Phase II trials for Alzheimer's disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Additionally, Pharnext collaborates with the University Hospital Institute Mediterranee Infection to evaluate repurposed drugs for potential COVID-19 treatment. Through its innovative approach, Pharnext aims to provide effective and safe treatments for diseases with limited therapeutic options.
Myopowers Medical Technologies is a French medical device company that develops innovative technologies to provide muscle assistance to patients with high unmet medical needs. The technology can be applied to a number of indications in the GI, cardiology or urology area. The company focus is the development of ARTUS, a new and unique implantable device for the treatment of stress urinary incontinence. Stress urinary incontinence is a condition that affects millions of people around the world. Unfortunately, currently available products are old with significant limitations such as tissue erosion, infection or mechanical failure leading frequent re-operation. ARTUS is made of smooth and flat silicon cuff placed around the urethra. It is individually actionable and adjustable with a remote control allowing patients easy voiding and the surgeon monitoring and adjusting the cuff. This device is the first artificial urinary system specifically designed to include the treatment of female patients who account for a vast majority of the urinary incontinence market.
Utel SAS, based in Paris, France, specializes in creating mobile applications for social networking and collaborative services. The company's flagship platform, Allokang, enables users to buy or sell skills, talents, and expertise across various fields, including legal, financial, academic support, IT, mental health, personal development, entertainment, and astrology. Additionally, Utel offers Backstage SMS, which provides tools for interactive engagement such as game initiation and voting, alongside a web interface that allows animators to manage listener messages and multimedia submissions. This functionality also enables monetization of community page traffic, allowing users to participate in paid activities. Established in 2000, Utel continues to innovate in the mobile application space.
Actility is an industry leader in Low Power Wide Area Networks (LPWAN). ThingPark by Actility offers a carrier-grade IoT platform, with a growing ecosystem of partners; low-power, long-range wireless networks for sensors and devices; an operating system and middleware that enables web applications to connect seamlessly with data from different sensors; and a B2B e-commerce market featuring tested and approved IoT device, connectivity, and application partners. Actility is a founding member of the LoRa Alliance™.
Pharnext SA is a clinical-stage biopharmaceutical company based in Issy-Les-Moulineaux, France, focused on developing therapies for orphan and common neurodegenerative diseases. Founded in 2007 by prominent scientists including Professor Daniel Cohen, Pharnext employs a novel approach called PLEOTHERAPY, which utilizes advanced genomic data and network pharmacology to discover new uses for existing drugs. This process identifies synergistic combinations of approved medications, leading to the development of new therapeutics known as PLEODRUGS. Key products include SYNGILITY, which has completed Phase III trials for Charcot-Marie-Tooth disease type 1A, and PXT864, which has shown promise in Phase II trials for Alzheimer's disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Additionally, Pharnext collaborates with the University Hospital Institute Mediterranee Infection to evaluate repurposed drugs for potential COVID-19 treatment. Through its innovative approach, Pharnext aims to provide effective and safe treatments for diseases with limited therapeutic options.
Immune Targeting Systems (ITS) Limited specializes in the development of synthetic vaccines aimed at combating mutating viruses. The company utilizes a T-cell vaccine platform that targets highly conserved viral antigens, directing the immune response specifically to infected cells. This innovative approach employs fluoropeptide vaccine technology, allowing for robust T-cell immunity without the need for potentially harmful adjuvants typically used to enhance vaccine efficacy. Founded in late 2003 and based in the London BioScience Innovation Centre, ITS has focused its efforts on creating vaccines for various viral infections, including seasonal and pandemic influenza, as well as life-threatening conditions such as HIV/AIDS and hepatitis. The company gained significant financial backing in 2007 from a group of investors, which included the Novartis Venture Fund and HealthCap, alongside support from the London Development Agency.
Symetis is a Swiss company based in Ecublens that specializes in developing innovative minimally invasive heart valve replacement therapies for patients with heart valve diseases, particularly aortic valve stenosis. The company focuses on enhancing patient care and safety by providing simple and accurate solutions for heart valve replacement. Its proprietary Acurate Aortic Valve Replacement System features a distinctive self-positioning design, which facilitates easy implant positioning and alignment, thereby improving the overall ease of use for healthcare providers. Through its advanced transcatheter aortic valve implantation devices, Symetis aims to address severe cardiac valve conditions and enhance treatment options within the healthcare industry.
Eco-Carbone
Funding Round in 2008
Eco-Carbone provides consulting and project development services in the area of climate change mitigation.
Carmat SA is a medtech company based in Vélizy-Villacoublay, France, specializing in the design and development of total artificial hearts for individuals suffering from end-stage biventricular heart failure. Founded in 2008, Carmat focuses on creating biocompatible, auto-regulated prosthetic hearts that closely mimic the function of natural human hearts. Its products are intended for patients with chronic terminal heart failure classified as New York Heart Association class IV, as well as those experiencing acute terminal heart failure after a significant myocardial infarction. The company aims to provide innovative therapeutic solutions for patients who are not candidates for heart transplants and have exhausted other treatment options. In addition to the artificial hearts, Carmat also develops associated power supply systems and control mechanisms for remote diagnosis.
Private Equity Round in 2007
OSEAD Maroc Mining operates as a metal and mining platform. OSEAD is a holding company specialising in the prospecting, exploration and mining of mineral deposits. OSEAD’s main asset is Compagnie Minière de Touissit the second largest private mining operator in Morocco, which mines primarily lead and silver with some zinc.
As of November 9, 2005, PeopleCube (UK) was acquired by PeopleCube, Inc. (formerly known as Meeting Maker, Inc.). PeopleCube provides intelligent on-demand workplace management solutions that help customers cut real estate, meeting services, travel, and energy costs based on actual workspace usage. Through its corporate headquarters in Framingham, Massachusetts, and offices throughout the world, PeopleCube supports 7,500 customers in small, medium, and large enterprises. PeopleCube helps businesses cut real estate, meeting services, travel and energy costs based on actual workspace usage. The UK predecessor, formerly known as The Internet Applications Group (UK), Ltd., was founded in 1995 and is based in Twickenham, the United Kingdom with an additional office in the Netherlands.
Neovacs S.A. is a biotechnology company based in Paris, France, that specializes in the development of therapeutic vaccines known as "Kinoids" for treating autoimmune, inflammatory diseases, allergies, and cancer. Founded in 1993 by Professor Daniel Zagury, the company aims to create innovative treatments that stimulate a natural polyclonal antibody response in patients, contrasting with traditional monoclonal antibody therapies. Neovacs' product pipeline includes IFNa Kinoid, which is undergoing Phase IIb clinical trials for systemic lupus erythematosus and Phase IIa trials for dermatomyositis, along with preclinical developments targeting diabetes. Additionally, the company is working on VEGF-Kinoid for age-related macular degeneration and solid tumors, and IL-4/IL-13 Kinoid for allergies. Neovacs also collaborates with the Sunnybrook Research Institute to advance preclinical research on VEGF-Kinoid for colorectal and ovarian cancer. The company holds a broad patent portfolio and is recognized as a pioneer in the field of therapeutic vaccines.
Immune Targeting Systems (ITS) Limited specializes in the development of synthetic vaccines aimed at combating mutating viruses. The company utilizes a T-cell vaccine platform that targets highly conserved viral antigens, directing the immune response specifically to infected cells. This innovative approach employs fluoropeptide vaccine technology, allowing for robust T-cell immunity without the need for potentially harmful adjuvants typically used to enhance vaccine efficacy. Founded in late 2003 and based in the London BioScience Innovation Centre, ITS has focused its efforts on creating vaccines for various viral infections, including seasonal and pandemic influenza, as well as life-threatening conditions such as HIV/AIDS and hepatitis. The company gained significant financial backing in 2007 from a group of investors, which included the Novartis Venture Fund and HealthCap, alongside support from the London Development Agency.
Cytomics Systems is a French private company that offers bio-pharmacology services. The company uses Yeast Micro-Lab technology, a protenomics tool, which enables to follow in-vitro deterioration of proteins. Cytomics Systems's research and development focuses on fungicidal infections, inflammatory illnesses, and cancers. Cytomics Systems, S.A was founded in 2000 and is based in Gif-sur-Yvette, France.
RF-iT Solutions GmbH specializes in radio frequency identification (RFID) software solutions and services. Founded in 2005 and headquartered in Graz, Austria, the company develops a range of products, including You-R® OPEN, an RFID operating environment designed for system integrators and software manufacturers. The company’s offerings include You-R Smart Fashion, a supply chain solution for the textile and apparel industry, You-R® DOCUTRACER, a web-based application for data storage aimed at patent lawyers and hospitals, You-R® PHARMA for pharmaceutical packaging, You-R® RETAIL for inventory management, You-R® SECURE for brand protection, and You-R® VIRTUAL TUNNEL for tracking product allocation. Additionally, RF-iT Solutions provides RFID middleware and consulting services, including business case analysis and feasibility studies. Its diverse client base spans various industries, such as fashion, automotive, industrial manufacturing, pharmaceuticals, retail, consumer packaged goods, logistics, asset management, and healthcare. The company also has locations in Germany, France, and the United Kingdom.
Deinove SA is a France-based company active in the renewable fuels sector. It specializes in the development and commercial exploitation of processes for production of biofuels and other compounds of industrial or pharmaceutical value.
Theradiag SA is a France-based company that specializes in the development, manufacturing, and marketing of in-vitro diagnostic products. Established in 1986 and located in Marne La Vallée, the company offers a range of solutions including autoimmunity reagents, quality control tools, and instruments for testing autoimmune and infectious diseases. Notable products include the SQA-V semen analyzer and the V-Sperm system for sample documentation. Theradiag also provides advanced instrumentation such as the Theralis platform, which integrates multiple diagnostic techniques, and the Theralis µ, designed for medium-sized laboratories. Additionally, the company offers therapeutic drug monitoring services for chronic inflammatory diseases and the LISA tracker, a tool for monitoring biotherapies.
AS Group
Funding Round in 2005
AS Group is a Parisian company and a spin-off of Deloitte, was a corporate performance software vendor.
EquiTime provides organizations with Workforce Management Solutions which allow them to build, follow, count and analyse employee schedules while respecting the specificities of each profession. EquiTime renews the traditional concepts of time and activity management by adding the forecasting dimension to that of the actual work already done, which represents a source of increased productivity, and an improvement in the relations between company employees and customers.
Theradiag SA is a France-based company that specializes in the development, manufacturing, and marketing of in-vitro diagnostic products. Established in 1986 and located in Marne La Vallée, the company offers a range of solutions including autoimmunity reagents, quality control tools, and instruments for testing autoimmune and infectious diseases. Notable products include the SQA-V semen analyzer and the V-Sperm system for sample documentation. Theradiag also provides advanced instrumentation such as the Theralis platform, which integrates multiple diagnostic techniques, and the Theralis µ, designed for medium-sized laboratories. Additionally, the company offers therapeutic drug monitoring services for chronic inflammatory diseases and the LISA tracker, a tool for monitoring biotherapies.